for patients who were candidates for radical resection with clinical stage IB, II, and IIIA NSCLC. Chemotherapy- and radiotherapy-naive patients were required to have stage I (except for T1N0), II, or ...

While glycoprotein (GP) IIb/IIIa inhibitors have been widely studied in ischemic stroke, cangrelor remains less explored. Objective To evaluate the safety and efficacy of cangrelor compared with GPIIb ...

Platelets in Cardiovascular Disease provides an in-depth and current coverage of relevant platelet biology and antiplatelet therapy that is in clinical use today and potentially for the future. The ...

Platelet adhesion is an essential function in response to vascular injury and is generally viewed as the first step during which single platelets bind through specific membrane receptors to cellular ...

To overcome this limitation, we hypothesized that platelet glycoprotein IIb/IIIa–targeted microbubbles (platelet-targeted microbubbles) could be used to increase the avidity of microbubbles to ...

“In practice, we see all too often [that] prophylactic transfusion of platelets or fresh frozen plasma is done unnecessarily,” says Angel Coz Yataco, MD, FCCP, lead author on the guideline.